Toshimasa Koyanagi

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B

Eiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta et al. · Liver International · 2020 · 59 citations

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study

Eiichi Ogawa, Makoto Nakamuta, Toshimasa Koyanagi et al. · Alimentary Pharmacology & Therapeutics · 2022 · 52 citations · Full text

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura et al. · Journal of Gastroenterology · 2016 · 50 citations

Cirrhotic Patients, Viral Hepatitis, Pathogenesis +11

Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis

Eiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura et al. · Antiviral Research · 2016 · 43 citations

Hepatology, Hepatitis C, Viral Hepatitis +9

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Eiichi Ogawa, Norihiro Furusyo, Makoto Nakamuta et al. · Hepatology Research · 2019 · 40 citations